Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
KeyBioscience Announces Extension of Strategic Collaboration with Lilly 2024-10-10 22:00
AIA Club Alta celebrates first anniversary Introducing brand-new infinite health programmes 2024-10-10 21:07
Newbase Inc. Unveils AI-Based VR Medical Education Platform 'Medicrew' 2024-10-10 21:00
ICCBBA Announces 2024 Enterprise Grant Awardees: Advancing Global Blood Safety 2024-10-10 20:00
USANA's First Become A USANA Coach Program: A Major Success and a Step Toward Healthier Communities 2024-10-10 18:13
Acer Medical: VeriOsteo OP Obtains Medical Device Approval from Indonesia's Ministry of Health 2024-10-10 10:00
Daewoong Pharmaceutical Unveils 'Innovative Drug Delivery Technologies' in Milan--From World's First Microneedle Therapy to Once-a-Month Obesity Treatment 2024-10-10 06:16
Centivax Selects Global CDMO BioCina to Initiate cGMP Manufacturing of Revolutionary Universal Influenza Vaccine 2024-10-09 23:37
Inaugural Health and Wellbeing Forum Discussed about Co-creating Healthier Hong Kong for all 2024-10-09 22:17
ZEISS expands ophthalmic offerings to improve patient care with new digital AI tools and revolutionary surgical solutions 2024-10-09 21:00
ShiraTronics Raises $66 Million in Oversubscribed Series B Financing to Advance Pioneering Treatment for Chronic Migraine 2024-10-09 20:12
International Collaboration Addresses Rising Cancer Rates in South America 2024-10-09 20:07
New INTREPID Alliance Antiviral Landscape Report Highlights Urgent Need to Bolster R&D Pipeline in Support of Global Pandemic Preparedness Efforts 2024-10-09 19:00
The CDE has Granted Breakthrough Therapy Designation to LBL-024, a Bispecific Antibody that Targets PD-L1 and 4-1BB, Developed by Leads Biolabs, for the Treatment of Extrapulmonary Neuroendocrine Carcinoma. 2024-10-09 13:38
AWAK Transforms into Vivance, Unveiling a New Brand Identity 2024-10-09 08:00
Seegene and Werfen Finalize Partnership Agreement on Technology-Sharing Initiative 2024-10-08 21:00
LakeShore Biopharma Provides Fiscal Half Year 2025 Financial Guidance and Reaffirms Fiscal Year 2025 Financial Guidance 2024-10-08 20:30
Pierre Fabre Laboratories and Scorpion Therapeutics Announce First Patient Dosed in Phase I/II Clinical Trial of PFL-241/STX-241, a Mutant-Selective Inhibitor Intended To Treat Locally Advanced or Metastatic Non-Small Cell Lung Cancer 2024-10-08 20:00
Healgen Scientific Receives FDA De Novo Marketing Authorization for At-Home COVID-19 and Influenza Test 2024-10-08 19:00
Registrational Phase III Studies of APG-2449 Cleared by China CDE for the Treatment of Patients with NSCLC 2024-10-08 10:26
1 8 9 10 11 12 531